Menu
GeneBe

rs76153698

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004937.3(CTNS):c.970+15G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0199 in 1,596,700 control chromosomes in the GnomAD database, including 468 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.032 ( 135 hom., cov: 34)
Exomes 𝑓: 0.019 ( 333 hom. )

Consequence

CTNS
NM_004937.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -3.27
Variant links:
Genes affected
CTNS (HGNC:2518): (cystinosin, lysosomal cystine transporter) This gene encodes a seven-transmembrane domain protein that functions to transport cystine out of lysosomes. Its activity is driven by the H+ electrochemical gradient of the lysosomal membrane. Mutations in this gene cause cystinosis, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 17-3659990-G-A is Benign according to our data. Variant chr17-3659990-G-A is described in ClinVar as [Benign]. Clinvar id is 257158.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-3659990-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0684 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CTNSNM_004937.3 linkuse as main transcriptc.970+15G>A intron_variant ENST00000046640.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CTNSENST00000046640.9 linkuse as main transcriptc.970+15G>A intron_variant 1 NM_004937.3 P1O60931-1

Frequencies

GnomAD3 genomes
AF:
0.0319
AC:
4852
AN:
152198
Hom.:
134
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0706
Gnomad AMI
AF:
0.0526
Gnomad AMR
AF:
0.0146
Gnomad ASJ
AF:
0.0187
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0205
Gnomad FIN
AF:
0.0309
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0162
Gnomad OTH
AF:
0.0263
GnomAD3 exomes
AF:
0.0201
AC:
5034
AN:
250196
Hom.:
94
AF XY:
0.0195
AC XY:
2643
AN XY:
135520
show subpopulations
Gnomad AFR exome
AF:
0.0681
Gnomad AMR exome
AF:
0.0101
Gnomad ASJ exome
AF:
0.0159
Gnomad EAS exome
AF:
0.000326
Gnomad SAS exome
AF:
0.0209
Gnomad FIN exome
AF:
0.0305
Gnomad NFE exome
AF:
0.0176
Gnomad OTH exome
AF:
0.0214
GnomAD4 exome
AF:
0.0186
AC:
26850
AN:
1444384
Hom.:
333
Cov.:
29
AF XY:
0.0184
AC XY:
13235
AN XY:
719412
show subpopulations
Gnomad4 AFR exome
AF:
0.0696
Gnomad4 AMR exome
AF:
0.0109
Gnomad4 ASJ exome
AF:
0.0170
Gnomad4 EAS exome
AF:
0.000126
Gnomad4 SAS exome
AF:
0.0208
Gnomad4 FIN exome
AF:
0.0303
Gnomad4 NFE exome
AF:
0.0171
Gnomad4 OTH exome
AF:
0.0230
GnomAD4 genome
AF:
0.0319
AC:
4857
AN:
152316
Hom.:
135
Cov.:
34
AF XY:
0.0317
AC XY:
2360
AN XY:
74480
show subpopulations
Gnomad4 AFR
AF:
0.0706
Gnomad4 AMR
AF:
0.0145
Gnomad4 ASJ
AF:
0.0187
Gnomad4 EAS
AF:
0.000386
Gnomad4 SAS
AF:
0.0205
Gnomad4 FIN
AF:
0.0309
Gnomad4 NFE
AF:
0.0162
Gnomad4 OTH
AF:
0.0260
Alfa
AF:
0.0240
Hom.:
11
Bravo
AF:
0.0321
Asia WGS
AF:
0.0180
AC:
62
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxDec 31, 2018- -
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicFeb 03, 2016- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJun 05, 2017Variant summary: The CTNS c.970+15G>A variant involves the alteration of a non-conserved intronic nucleotide at a position not widely known to affect gene splicing. Mutation taster predicts a benign outcome for this variant. This variant was found in 2496/120078 control chromosomes (45 homozygotes) from ExAC at a frequency of 0.0207865, which is approximately 8 times the estimated maximal expected allele frequency of a pathogenic CTNS variant (0.0025), suggesting this variant is likely a benign polymorphism. It is more common in African subpopulation with an allele frequency of 6.5% (674/10238 chromosomes). This variant was found in a cystinosis patient who carried c.140+1G>T in homozygous state, further supporting benign outcome of the variant of interest. In addition, multiple clinical diagnostic laboratories/reputable databases have classified this variant as likely benign/benign. Taken together, this variant is classified as benign. -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Ocular cystinosis Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Nephropathic cystinosis Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Juvenile nephropathic cystinosis;C0950123:Inborn genetic diseases;C2931013:Ocular cystinosis Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
Cadd
Benign
0.027
Dann
Benign
0.89

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs76153698; hg19: chr17-3563284; API